These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7800073)

  • 61. Cellular immunity in Crohn's disease.
    Kraft SC
    Gastroenterology; 1971 Oct; 61(4):545-8. PubMed ID: 4939936
    [No Abstract]   [Full Text] [Related]  

  • 62. Alterations of the immune system in ulcerative colitis and Crohn's disease.
    MacDermott RP; Stenson WF
    Adv Immunol; 1988; 42():285-328. PubMed ID: 3284291
    [No Abstract]   [Full Text] [Related]  

  • 63. Demonstration of an assay for specific cytolytic antibody in sera from patients with ulcerative colitis.
    Nagai T; Das KM
    Gastroenterology; 1981 Jun; 80(6):1507-12. PubMed ID: 7227776
    [No Abstract]   [Full Text] [Related]  

  • 64. NICE calls for more research on ELISA tests for Crohn's disease.
    Wise J
    BMJ; 2016 Feb; 352():i1019. PubMed ID: 26892621
    [No Abstract]   [Full Text] [Related]  

  • 65. HLA, antineutrophil cytoplasmic autoantibody, and heterogeneity in ulcerative colitis.
    Asakura H; Sugimura K
    Gastroenterology; 1995 Feb; 108(2):597-9. PubMed ID: 7835603
    [No Abstract]   [Full Text] [Related]  

  • 66. Anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel diseases (IBD).
    Nakato T; Fukushima M; Yamamoto H
    Gastroenterol Jpn; 1992 Oct; 27(5):683. PubMed ID: 1426860
    [No Abstract]   [Full Text] [Related]  

  • 67. Specific inhibition of the in vitro migration of leucocytes in ulcerative colitis and Crohn's disease.
    Bendixen G
    Scand J Gastroenterol; 1967; 2(3):214-21. PubMed ID: 6050716
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of sarcoid spleen suspension on in vitro leukocyte migration in Crohn's disease.
    Willoughby JM; Mitchell D
    Gut; 1971 Jun; 12(6):496. PubMed ID: 5090879
    [No Abstract]   [Full Text] [Related]  

  • 69. Expression of CD44 variants in differential diagnosis of ulcerative colitis and Crohn's disease.
    Papadogiannakis N; Gad A; Chenard MP; Bellocq JP; Duclos B
    Lancet; 1996 May; 347(9012):1413-4. PubMed ID: 8637372
    [No Abstract]   [Full Text] [Related]  

  • 70. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
    Mehal WZ; Lo SK; Chapman RW; Fleming KA
    J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
    [No Abstract]   [Full Text] [Related]  

  • 71. [Autoimmune mechanisms in colonic and intestinal diseases].
    Galvan ES; Villaggi Leiva JC
    Prensa Med Argent; 1970 May; 57(13):622-8. PubMed ID: 5517720
    [No Abstract]   [Full Text] [Related]  

  • 72. HLA antigens in inflammatory bowel disease.
    Hiwatashi N; Kikuchi T; Masamune O; Ouchi E; Watanabe H; Goto Y
    Tohoku J Exp Med; 1980 Aug; 131(4):381-5. PubMed ID: 7466804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunoglobulins in non-specific ulcerative disease of the colon.
    Schofield PF; Deodhar SD; Turnbull RB
    Br J Surg; 1969 May; 56(5):389. PubMed ID: 4181058
    [No Abstract]   [Full Text] [Related]  

  • 74. [Immunologic studies in patients with ulcerative colitis].
    Györffy A; Dalmi L; Papp L; Szabó G
    Orv Hetil; 1974 Jul; 115(30):1763-5. PubMed ID: 4848919
    [No Abstract]   [Full Text] [Related]  

  • 75. Proceedings: Phase-specific oncocolon antigens: a theoretical framework for "carcinoembryonic antigen" specificities.
    Rule AH; Goleski-Reilly C
    Cancer Res; 1974 Aug; 34(8):2083-7. PubMed ID: 4135228
    [No Abstract]   [Full Text] [Related]  

  • 76. HLA-A and -B antigens in inflammatory bowel disease.
    Biemond I; Burnham WR; D'Amaro J; Langman MJ
    Gut; 1986 Aug; 27(8):934-41. PubMed ID: 3460939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.
    Lagercrantz R; Hammarström S; Perlmann P; Gustafsson BE
    Clin Exp Immunol; 1966 Jul; 1(3):263-76. PubMed ID: 5330184
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Changes in the immunological indicators in nonspecific ulcerative colitis after treatment].
    Gerasimov VK
    Ter Arkh; 1979; 51(11):99-102. PubMed ID: 524293
    [No Abstract]   [Full Text] [Related]  

  • 79. Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures.
    Parent K; Barrett J; Wilson ID
    Gastroenterology; 1971 Oct; 61(4):431-9. PubMed ID: 5165501
    [No Abstract]   [Full Text] [Related]  

  • 80. [Immunity aspects of the pathogenesis of ulcerative colitis].
    Jori GP; Mazzacca G
    Recenti Prog Med; 1968 Jun; 44(6):571-84. PubMed ID: 5757227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.